Houston Methodist
Abiraterone acetate plus prednisolone ‘new standard of care’ in prostate cancer subset
Two years of abiraterone acetate plus prednisolone-based therapy significantly improved survival among men with high-risk nonmetastatic prostate cancer starting androgen deprivation therapy, according to results of the STAMPEDE trial.
Adding abiraterone acetate to standard of care prolongs survival in prostate cancer subset
Adding abiraterone acetate to androgen deprivation therapy plus docetaxel improved radiographic PFS and OS among men with metastatic castration-sensitive prostate cancer, according to data presented during the virtual ESMO Congress 2021.
Intraosseous vancomycin reduces 90-day periprosthetic joint infection rate after TKA
Intraosseous delivery of vancomycin after tourniquet inflation is safe and effective for reducing periprosthetic joint infection after primary total knee arthroplasty, according to published results.
Income, food security correlate to use of COVID-19 mitigation practices in CVD
Individuals with CVD and greater burden regarding social determinants of health were less likely to practice COVID-19 risk mitigation measures such as personal protection and social distancing, a speaker reported.
ACL reconstruction with femoral cortical button fixation yielded good 20-year outcomes
More than 20 years after patients underwent ACL reconstruction with hamstring tendon graft and femoral cortical button fixation, they had a low failure rate, low awareness of the operated knee and good clinical stability.
Comfort care interventions improve quality of life for patients with stroke
Comfort care interventions could improve quality of life in hospitalized patients with stroke, but disparities related to sex, race and income should be addressed, researchers reported.